article Open AccessTop 1% cited
Folate receptor alpha as a tumor target in epithelial ovarian cancer
Gynecologic Oncology · 2008 · Vol. 108(3) · pp. 619–626
Kimberly R. Kalli✉(Mayo Clinic)Ann L. Oberg(Mayo Clinic)Gary L. Keeney(Mayo Clinic)Teresa J. Christianson(Mayo Clinic)Philip S. Low(Purdue University Institute for Cancer Research)Keith L. Knutson(Mayo Clinic)Lynn C. Hartmann(Mayo Clinic in Arizona)
Ovarian cancer diagnosis and treatmentChromatin Remodeling and CancerLymphoma Diagnosis and TreatmentMedicineDebulkingImmunohistochemistryOvarian cancerSerous fluidFolate receptorStage (stratigraphy)PathologyOncologyCancer
MeSH terms
Adenocarcinoma, MucinousCarrier ProteinsFemaleHumansImmunohistochemistryMedical RecordsMiddle AgedMinnesotaNeoplasm MetastasisNeoplasm Recurrence, LocalOvarian NeoplasmsReceptors, Cell SurfaceRetrospective StudiesGene Expression Regulation, NeoplasticSurvival Analysis
Funding
- Minnesota Ovarian Cancer Alliance
Citations
454
FWCI
18.11
field-weighted impact
References
47
Percentile
99%
vs. same field & year
Citations per year
Cited by
Targeting folate receptor alpha for cancer treatment
Oncotarget · 2016 · 443 citations
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
CA A Cancer Journal for Clinicians · 2019 · 1,454 citations
References
Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics
Journal of Pharmaceutical Sciences · 2005 · 622 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.